Ryan McGrath1, Brenda M Vincent2, Mark D Peterson3, Donald A Jurivich4, Lindsey J Dahl4, Kyle J Hackney5, Brian C Clark6. 1. Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND. Electronic address: ryan.mcgrath@ndsu.edu. 2. Department of Statistics, North Dakota State University, Fargo, ND. 3. Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI. 4. Department of Geriatrics, University of North Dakota, Grand Forks, ND; Sanford Health, Fargo, ND. 5. Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND. 6. Ohio Musculoskeletal and Neurological Institute, Ohio University, Athens, OH; Department of Biomedical Sciences, Ohio University, Athens, OH; Department of Geriatric Medicine, Ohio University, Athens, OH.
Abstract
OBJECTIVES: Quantifying the association between muscle weakness and mortality with carefully matched cohorts will help to better establish the impact of weakness on premature death. We used a matched cohort analysis in a national sample of older Americans to determine if those who were weak had a higher risk for mortality compared with control groups with incrementally higher strength capacities. DESIGN: Longitudinal panel. SETTING: Detailed interviews that included physical measures were conducted in person, whereas core interviews were often performed over the telephone. PARTICIPANTS: Data from 19,729 Americans aged at least 50 years from the 2006-2014 waves of the Health and Retirement Study were analyzed. MEASURES: A handgrip dynamometer was used to assess handgrip strength (HGS) in each participant. Men with HGS <26 kg were considered weak, ≥26 kg were considered not weak, and ≥32 kg were considered strong. Women with HGS <16 kg were classified as weak, ≥16 kg were classified as not-weak, and ≥20 kg were classified as strong. The National Death Index and postmortem interviews determined the date of death. The greedy matching algorithm was used to match cohorts. RESULTS: Of the 1077 weak and not-weak matched pairs, 401 weak (37.2%) and 296 not-weak (27.4%) older Americans died over an average 4.4 ± 2.5-year follow-up. There were 392 weak (37.0%) and 243 strong (22.9%) persons who died over a mean 4.5 ± 2.5-year follow-up from the 1057 weak and strong matched pairs. Those in the weak cohort had a 1.40 [95% confidence interval (CI) 1.19, 1.64] and 1.54 (CI 1.30, 1.83) higher hazard for mortality relative to persons in the not-weak and strong control cohorts, respectively. CONCLUSIONS AND IMPLICATIONS: Our findings may indicate a causal association between muscle weakness and mortality in older Americans. Health care providers should include measures of HGS as part of routine health assessments and discuss the health risks of muscle weakness with their patients.
OBJECTIVES: Quantifying the association between muscle weakness and mortality with carefully matched cohorts will help to better establish the impact of weakness on premature death. We used a matched cohort analysis in a national sample of older Americans to determine if those who were weak had a higher risk for mortality compared with control groups with incrementally higher strength capacities. DESIGN: Longitudinal panel. SETTING: Detailed interviews that included physical measures were conducted in person, whereas core interviews were often performed over the telephone. PARTICIPANTS: Data from 19,729 Americans aged at least 50 years from the 2006-2014 waves of the Health and Retirement Study were analyzed. MEASURES: A handgrip dynamometer was used to assess handgrip strength (HGS) in each participant. Men with HGS <26 kg were considered weak, ≥26 kg were considered not weak, and ≥32 kg were considered strong. Women with HGS <16 kg were classified as weak, ≥16 kg were classified as not-weak, and ≥20 kg were classified as strong. The National Death Index and postmortem interviews determined the date of death. The greedy matching algorithm was used to match cohorts. RESULTS: Of the 1077 weak and not-weak matched pairs, 401 weak (37.2%) and 296 not-weak (27.4%) older Americans died over an average 4.4 ± 2.5-year follow-up. There were 392 weak (37.0%) and 243 strong (22.9%) persons who died over a mean 4.5 ± 2.5-year follow-up from the 1057 weak and strong matched pairs. Those in the weak cohort had a 1.40 [95% confidence interval (CI) 1.19, 1.64] and 1.54 (CI 1.30, 1.83) higher hazard for mortality relative to persons in the not-weak and strong control cohorts, respectively. CONCLUSIONS AND IMPLICATIONS: Our findings may indicate a causal association between muscle weakness and mortality in older Americans. Health care providers should include measures of HGS as part of routine health assessments and discuss the health risks of muscle weakness with their patients.
Authors: Hannah G Lawman; Richard P Troiano; Frank M Perna; Chia-Yih Wang; Cheryl D Fryar; Cynthia L Ogden Journal: Am J Prev Med Date: 2015-12-11 Impact factor: 5.043
Authors: Amanda Sonnega; Jessica D Faul; Mary Beth Ofstedal; Kenneth M Langa; John W R Phillips; David R Weir Journal: Int J Epidemiol Date: 2014-03-25 Impact factor: 7.196
Authors: Stephanie Studenski; Subashan Perera; Kushang Patel; Caterina Rosano; Kimberly Faulkner; Marco Inzitari; Jennifer Brach; Julie Chandler; Peggy Cawthon; Elizabeth Barrett Connor; Michael Nevitt; Marjolein Visser; Stephen Kritchevsky; Stefania Badinelli; Tamara Harris; Anne B Newman; Jane Cauley; Luigi Ferrucci; Jack Guralnik Journal: JAMA Date: 2011-01-05 Impact factor: 56.272
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Michael Cusick; Annal D Meleth; Elvira Agrón; Marion R Fisher; George F Reed; Genell L Knatterud; Franca B Barton; Matthew D Davis; Frederick L Ferris; Emily Y Chew Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: Francesco Gilardi; Paola Scarcella; Maria Grazia Proietti; Giovanni Capobianco; Gennaro Rocco; Alessandra Capanna; Sandro Mancinelli; Maria Cristina Marazzi; Leonardo Palombi; Giuseppe Liotta Journal: Eur J Public Health Date: 2018-10-01 Impact factor: 3.367
Authors: Ryan McGrath; Grant R Tomkinson; Brian C Clark; Peggy M Cawthon; Matteo Cesari; Soham Al Snih; Donald A Jurivich; Kyle J Hackney Journal: J Am Med Dir Assoc Date: 2021-06-21 Impact factor: 4.669
Authors: Ryan McGrath; Terri L Blackwell; Kristine E Ensrud; Brenda M Vincent; Peggy M Cawthon Journal: J Gerontol A Biol Sci Med Sci Date: 2021-08-13 Impact factor: 6.053